logo

Pultegroup, Inc. (PHM)



Trade PHM now with
  Date
  Headline
8/3/2018 8:03:06 AM FDA Grants Orphan Drug Designation To PharmaMar's Lurbinectedin
7/27/2018 7:46:55 AM Wedbush Is Increasing PulteGroup, Inc. (PHM) FY19 Rev. Estimate To 10.39 Billion From 10.20 Billion
7/27/2018 7:46:36 AM Wedbush Is Increasing PulteGroup, Inc. (PHM) Q4 19 Rev. Estimate To 3.27 Billion From 3.12 Billion
7/27/2018 7:46:18 AM Wedbush Is Cutting PulteGroup, Inc. (PHM) Q3 19 Rev. Estimate To 2.68 Billion From 2.69 Billion
7/27/2018 7:45:56 AM Wedbush Is Increasing PulteGroup, Inc. (PHM) Q2 19 Rev. Estimate To 2.44 Billion From 2.43 Billion
7/27/2018 7:45:37 AM Wedbush Is Raising PulteGroup, Inc. (PHM) Q1 19 Rev. Estimate To 2.00 Billion From 1.96 Billion
7/27/2018 7:45:11 AM Wedbush Is Raising PulteGroup, Inc. (PHM) FY18 Rev. Estimate To 10.06 Billion From 9.85 Billion
7/27/2018 7:44:50 AM Wedbush Is Lowering PulteGroup, Inc. (PHM) Q4 18 Rev. Estimate To 2.83 Billion From 2.95 Billion
7/27/2018 7:44:29 AM Wedbush Is Raising PulteGroup, Inc. (PHM) Q3 18 Rev. Estimate To 2.68 Billion From 2.56 Billion
7/27/2018 7:43:43 AM Wedbush Is Raising PulteGroup, Inc. (PHM) FY19 Estimate To 3.72 From 3.38
7/27/2018 7:43:27 AM Wedbush Is Cutting PulteGroup, Inc. (PHM) Q4 19 Estimate To 1.12 From 1.14
7/27/2018 7:42:58 AM Wedbush Is Increasing PulteGroup, Inc. (PHM) Q3 19 Estimate To 0.98 From 0.93
7/27/2018 7:42:45 AM Wedbush Is Increasing PulteGroup, Inc. (PHM) Q2 19 Estimate To 0.88 From 0.75
7/27/2018 7:42:34 AM Wedbush Is Raising PulteGroup, Inc. (PHM) Q1 19 Estimate To 0.62 From 0.56
7/27/2018 7:42:15 AM Wedbush Is Raising PulteGroup, Inc. (PHM) FY18 Estimate To 3.68 From 3.13
7/27/2018 7:41:51 AM Wedbush Is Increasing PulteGroup, Inc. (PHM) Q3 18 Estimate To 0.94 From 0.84
7/27/2018 7:41:21 AM Wedbush Reiterates PulteGroup, Inc. (PHM) At Neutral With $32 Price Target
7/26/2018 6:33:32 AM PulteGroup Q2 Reported Net Income $324.09 Mln Or $1.12/Shr Vs $101 Mln Or $0.32/Shr Last Year